Cargando…
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic
Autores principales: | Jacob, Saiju, Muppidi, Srikanth, Guidon, Amanda, Guptill, Jeffrey, Hehir, Michael, Howard, James F., Illa, Isabel, Mantegazza, Renato, Murai, Hiroyuki, Utsugisawa, Kimiaki, Vissing, John, Wiendl, Heinz, Nowak, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105910/ https://www.ncbi.nlm.nih.gov/pubmed/32247193 http://dx.doi.org/10.1016/j.jns.2020.116803 |
Ejemplares similares
-
A Patient with Coexisting Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome
por: Kim, Jee-Ae, et al.
Publicado: (2012) -
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
por: Muppidi, Srikanth, et al.
Publicado: (2020) -
Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: New Developments in Diagnosis and Treatment
por: Pascuzzi, Robert M, et al.
Publicado: (2022) -
Amifampridine for Lambert-Eaton myasthenic syndrome
Publicado: (2022) -
Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan
por: Yoshikawa, Hiroaki, et al.
Publicado: (2022)